Atlas Arteria (ASX:ALX) Beta: 0.6404 (As of Jun. 24, 2026)


ASX:ALX Atlas Arteria Ltd ASX:ALX
75 GF Score
Price A$5.10
GF Value A$5.86
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Atlas Arteria Beta?

Atlas Arteria ASX:ALX 75 Beta is 0.6404 as of Jun. 24, 2026. GuruFocus rates ASX:ALX with a GF Score™ of 75/100 and a GF Value™ of A$5.86 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-24), Atlas Arteria's Beta is 0.6404.


Atlas Arteria  (ASX:ALX) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Atlas Arteria Beta Related Terms


Atlas Arteria Beta Historical Data

* Premium members only.

The historical data trend for Atlas Arteria's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atlas Arteria Beta Chart

Atlas Arteria Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.27 1.02 0.52 0.42 0.64

Atlas Arteria Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 0.50 0.42 0.84 0.64

Atlas Arteria Beta Competitor Comparison

For the Infrastructure Operations subindustry, Atlas Arteria's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atlas Arteria Beta vs Construction Industry

For the Construction industry and Industrials sector, Atlas Arteria's Beta distribution charts can be found below:

* The bar in red indicates where Atlas Arteria's Beta falls into.


ASX:ALX
75GF Score
Atlas Arteria Ltd ASX:ALX
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atlas Arteria Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.6404 mean?
Atlas Arteria (ASX:ALX) has a Beta of 0.6404 as of Jun. 24, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Atlas Arteria and its competitors.
Is Atlas Arteria's Beta too high?
Atlas Arteria's current Beta is 0.6404. Overall, Atlas Arteria has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Atlas Arteria's Beta compare to competitors?
Atlas Arteria's Beta of 0.6404 can be compared against companies in the Construction industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Construction company?
A good Beta depends on the Construction industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Atlas Arteria and its competitors. Atlas Arteria's current Beta is 0.6404. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atlas Arteria stock overvalued right now?
Based on GuruFocus' analysis, Atlas Arteria (ASX:ALX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$5.86, compared to a current price of A$5.10 — trading 13% below its estimated fair value. The current Beta is 0.6404. Atlas Arteria's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Atlas Arteria (ASX:ALX), the current Beta is 0.6404 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Atlas Arteria (ASX:ALX) Overvalued in 2026?

Based on GuruFocus' analysis, Atlas Arteria stock appears to be undervalued. The current stock price of A$5.10 is trading 13% below its estimated GF Value™ of A$5.86. GuruFocus considers Atlas Arteria to be Modestly Undervalued.

Key valuation signals for ASX:ALX:

  • Beta: 0.6404
  • GF Value™: A$5.86 vs. price of A$5.10 (13% below fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the ASX:ALX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Atlas Arteria Business Description

Other Exchanges MAQAF:USAM82:Germany
Address 180 Flinders Street, Level 1, Melbourne, VIC, AUS, 3000
Atlas Arteria is a global toll-road investor created out of the reorganization of Macquarie Infrastructure Group in 2010. The firm's main asset is a 30.82% stake in APRR. APRR owns concessions to toll more than 2,300 kilometers of motorways in eastern France, most ending by late 2035. The firm also wholly owns the Dulles Greenway and 66.67% of the Chicago Skyway, both in the US.
75GF Score

Get the complete analysis for ASX:ALX

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$5.10
Price
A$5.86
GF Value